← FDA DRUG APPROVALS

FDA ANDA · ANDA207971

FINGOLIMOD HYDROCHLORIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA207971
TYPE
ANDA
ORIGINAL APPROVAL
2020-06-29
LATEST ACTION
2026-02-18
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

FINGOLIMOD HYDROCHLORIDEDiscontinued
FINGOLIMOD HYDROCHLORIDE EQ 0.5MG BASE · CAPSULE · ORAL

Approval history

2026-02-18Labeling · Supplement 4 · standardAP
2026-02-18Labeling · Supplement 3 · standardAP
2020-06-29UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →